Frontage Labs to Expand CMC Facility in PennsylvaniaBy
Frontage Labs, a contract manufacturing organization, plans to expand its chemistry, manufacturing and controls (CMC) facility in Exton, Pennsylvania. The renovation plan, which involves two phase, includes incremental capacity expansions to existing services and the opportunity for future growth.
Initial enhancements, which will include two analytical laboratories and 8000 square feet of office space, will begin in mid-2014, with completion scheduled for the end of September 2014. The second phase, which includes additional clinical-trial material (CTM) manufacturing space for solid, semi-solid and sterile pharmaceutical products, packaging, labeling, and distribution functions, will be implemented at the beginning of 2015. Following the completion of this expansion in mid-2015, Frontage expects to increase its CMC workforce and capacity by more than 50%.
Frontage's CMC service portfolio includes organic synthesis, formulation development, GMP analytical testing, and GMP CTM manufacturing, for all types of drug candidates ranging from novel, early phase projects to generic-equivalent and consumer care medications.
Source: Frontage Labs